Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine.

Improved adjuvanting of seasonal influenza vaccines: preclinical studies of MVA-NP+M1 coadministration with inactivated influenza vaccine.

Licensed seasonal influenza vaccines induce antibody (Ab) responses against influenza hemagglutinin (HA) that are limited in their ability to protect against different strains of influenza. Cytotoxic T lymphocytes recognizing the conserved internal nucleoprotein (NP) and matrix protein (M1) are capa...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Mullarkey, C, Boyd, A, van Laarhoven, A, Lefevre, E, Veronica Carr, B, Baratelli, M, Molesti, E, Temperton, N, Butter, C, Charleston, B, Lambe, T, Gilbert, S
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2013

Παρόμοια τεκμήρια

Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses
ανά: Antrobus, R, κ.ά.
Έκδοση: (2014)

Coadministration of seasonal influenza vaccine and MVA-NP+M1 simultaneously achieves potent humoral and cell-mediated responses.
ανά: Antrobus, R, κ.ά.
Έκδοση: (2014)

Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans.
ανά: Lillie, P, κ.ά.
Έκδοση: (2012)

Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine
ανά: Powell, T, κ.ά.
Έκδοση: (2013)

Examination of influenza specific T cell responses after influenza virus challenge in individuals vaccinated with MVA-NP+M1 vaccine.
ανά: Timothy J Powell, κ.ά.
Έκδοση: (2013-01-01)

Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.
ανά: Berthoud, T, κ.ά.
Έκδοση: (2011)

A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years.
ανά: Antrobus, R, κ.ά.
Έκδοση: (2012)

Immunity against heterosubtypic influenza virus induced by adenovirus and MVA expressing nucleoprotein and matrix protein-1.
ανά: Lambe, T, κ.ά.
Έκδοση: (2013)

A T cell-inducing influenza vaccine for the elderly: safety and immunogenicity of MVA-NP+M1 in adults aged over 50 years.
ανά: Richard D Antrobus, κ.ά.
Έκδοση: (2012-01-01)

Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies
ανά: Cécile Janssen, κ.ά.
Έκδοση: (2022-11-01)

Newly Designed Poxviral Promoters to Improve Immunogenicity and Efficacy of MVA-NP Candidate Vaccines against Lethal Influenza Virus Infection in Mice
ανά: Martin C. Langenmayer, κ.ά.
Έκδοση: (2023-06-01)

Adenoviral vectors as novel vaccines for influenza.
ανά: Coughlan, L, κ.ά.
Έκδοση: (2015)

Novel MVA-based vaccine expressing influenza NP and M1 activates cross-reactive T cell responses in human nasopharynx-associated lymphoid tissue (NALT) (conference abstract)
ανά: Puksuriwong, S, κ.ά.
Έκδοση: (2018)

T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine.
ανά: Lambe, T, κ.ά.
Έκδοση: (2012)

T-cell responses in children to internal influenza antigens, 1 year after immunization with pandemic H1N1 influenza vaccine, and response to revaccination with seasonal trivalent-inactivated influenza vaccine
ανά: Lambe, T, κ.ά.
Έκδοση: (2012)

Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.
ανά: Ota, M, κ.ά.
Έκδοση: (2011)

Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants
ανά: Ota, M, κ.ά.
Έκδοση: (2011)

Novel bivalent viral-vectored vaccines induce potent humoral and cellular immune responses conferring protection against stringent influenza a virus challenge
ανά: Tully, C, κ.ά.
Έκδοση: (2017)

Development of NP-Based Universal Vaccine for Influenza A Viruses
ανά: Ekramy E. Sayedahmed, κ.ά.
Έκδοση: (2024-02-01)

A phase IIb study to determine the safety and efficacy of candidate INfluenza Vaccine MVA-NP+M1 in combination with licensed InaCTivated inflUenza vaccine in adultS aged 65 years and above (INVICTUS): a study protocol
ανά: Swayze, H, κ.ά.
Έκδοση: (2019)

Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responsesResearch in context
ανά: David Pattinson, κ.ά.
Έκδοση: (2024-05-01)

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line
ανά: Pedro M. Folegatti, κ.ά.
Έκδοση: (2019-03-01)

Uneventful Coadministration of Seasonal Influenza and COVID-19 BNT162b2 Vaccines Two Weeks Post-Influenza Vaccination in an Egg-Allergic Subject: A Case Report
ανά: Anwar A. Sayed
Έκδοση: (2023-05-01)

Coadministration of 13-valent pneumococcal conjugate and quadrivalent inactivated influenza vaccines in adults previously immunized with polysaccharide pneumococcal vaccine 23: a randomized clinical trial
ανά: Allison R. Thompson, κ.ά.
Έκδοση: (2019-02-01)

Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured onthe AGE1.CR.pIX Avian Cell Line
ανά: Folegatti, P, κ.ά.
Έκδοση: (2019)

Clinical advances in viral-vectored influenza vaccines
ανά: Sebastian, S, κ.ά.
Έκδοση: (2018)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
ανά: Saranya Sridhar, κ.ά.
Έκδοση: (2015-04-01)

Clinical Advances in Viral-Vectored Influenza Vaccines
ανά: Sarah Sebastian, κ.ά.
Έκδοση: (2018-05-01)

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
ανά: Wei Dong, κ.ά.
Έκδοση: (2018-10-01)

Safety of routine childhood vaccine coadministration versus separate vaccination
ανά: Bauwens, J, κ.ά.
Έκδοση: (2022)

Safety of routine childhood vaccine coadministration versus separate vaccination
ανά: Simon de Lusignan, κ.ά.
Έκδοση: (2022-09-01)

Preclinical study of immunogenicity of adjuvanted quadrivalent subunit influenza vaccine
ανά: I. V. Krasilnikov, κ.ά.
Έκδοση: (2022-07-01)

Inactivated recombinant influenza vaccine: the promising direction for the next generation of influenza vaccine
ανά: Hua Shi, κ.ά.
Έκδοση: (2024-12-01)

Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
ανά: Arunkumar, G, κ.ά.
Έκδοση: (2019)

Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge
ανά: McMahon, M, κ.ά.
Έκδοση: (2019)

Influenza and influenza vaccination in children
ανά: Viorel ALEXANDRESCU, κ.ά.
Έκδοση: (2017-09-01)

Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach
ανά: Irene González-Domínguez, κ.ά.
Έκδοση: (2024-11-01)

Intranasal inactivated influenza vaccines for the prevention of seasonal influenza epidemics
ανά: Kaori Sano, κ.ά.
Έκδοση: (2018-08-01)

Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines
ανά: Teresa Hauguel, κ.ά.
Έκδοση: (2024-10-01)

Towards a universal vaccine for avian influenza: protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus.
ανά: Boyd, A, κ.ά.
Έκδοση: (2013)